{"schema_version":"secwatch.filing_event.v1","accession":"0001650664-24-000050","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2024-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.428911+00:00","generated_at":"2026-06-01T07:10:57.042325+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Editas Medicine stockholders elect Class II directors, approve say-on-pay, ratify auditor","bullets":["Elected Meeta Chatterjee, Andrew Hirsch, Gilmore O'Neill as Class II directors for term until 2027 annual meeting.","Advisory say-on-pay approved with 38,609,828 votes for, 2,769,887 against, 205,788 abstentions.","Ratified Ernst & Young as independent auditor for fiscal 2024 with 57,952,408 votes for, 362,117 against, 1,036,297 abstentions.","Broker non-votes of 17,765,319 on director election and say-on-pay; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001650664-24-000050","json":"https://secwatch.observer/filing/0001650664-24-000050.json","markdown":"https://secwatch.observer/filing/0001650664-24-000050.md","text":"https://secwatch.observer/filing/0001650664-24-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/0001650664-24-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/edit-20240530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:10:57.042325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}